Graviton Bioscience
Julia Balanova has held various roles in investor relations, corporate strategy, and communications in companies such as Graviton Bioscience, Faron, and BenevolentAI. With a background in healthcare analysis and portfolio management, Julia brings a wealth of experience to their current position as VP of Corporate Strategy and Communications. Julia graduated from Lomonosov Moscow State University (MSU).
Graviton Bioscience
Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.